Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angela Dispenzieri

Showing results (111-120 of 904) with videos related to

Pageof 91
Sort By:
British Journal of Haematology|April 11, 2025
The molecular landscape of AL amyloidosisTal Zvida-Bloch, Eli Muchtar, Angela Dispenzieri, et al.
AMIA ... Annual Symposium Proceedings. AMIA Symposium|April 21, 2020
Achievability to Extract Specific Date Information for Cancer ResearchLiwei Wang, Jason Wampfler, Angela Dispenzieri, et al.
Archives of Dermatology|October 18, 2006
Dermatologic adverse effects of lenalidomide therapy for amyloidosis and multiple myelomaHans P Sviggum, Mark D P Davis, S Vincent Rajkumar, et al.
Neurology|September 12, 2007
Primary systemic amyloidosis with ischemic stroke as a presenting complicationAlexander Y Zubkov, Alejandro A Rabinstein, Angela Dispenzieri, et al.
JACC. Cardiooncology|June 19, 2025
Reply: Cardiac Biomarkers in Patients With Suspected Amyloid (Transthyretin) Cardiomyopathy: Which Cut-Offs?Laura De Michieli, Omar F AbouEzzeddine, Angela Dispenzieri, et al.
Journal of the American College of Cardiology|September 24, 2021
Cardiac Amyloidosis in Patients With Persistent Left Atrial ThrombusEdward A El-Am, Ali Ahmad, Angela Dispenzieri, et al.
International Journal of Molecular Sciences|November 20, 2013
Thermal stability threshold for amyloid formation in light chain amyloidosisTanya L Poshusta, Nagaaki Katoh, Morie A Gertz, et al.
International Journal of Cancer|February 2, 2021
Chemotherapy-based approach is the preferred treatment for sporadic late-onset nemaline myopathy with a monoclonal proteinRouslan Kotchetkov, David Susman, Divaya Bhutani, et al.
International Journal of Cancer|March 20, 2021
Reply to: Comments on: Chemotherapy-based approach is the preferred treatment for sporadic late-onset nemaline myopathy with a monoclonal proteinRouslan Kotchetkov, David Susman, Divaya Bhutani, et al.
Current Opinion in Oncology|February 3, 2007
Transplantation for amyloidosisMorie A Gertz, Martha Q Lacy, Angela Dispenzieri, et al.
Pageof 91

Showing results (111-120 of 904) with videos related to

Sort By:
Pageof 91
British Journal of Haematology|April 11, 2025
The molecular landscape of AL amyloidosisTal Zvida-Bloch, Eli Muchtar, Angela Dispenzieri, et al.
AMIA ... Annual Symposium Proceedings. AMIA Symposium|April 21, 2020
Achievability to Extract Specific Date Information for Cancer ResearchLiwei Wang, Jason Wampfler, Angela Dispenzieri, et al.
Archives of Dermatology|October 18, 2006
Dermatologic adverse effects of lenalidomide therapy for amyloidosis and multiple myelomaHans P Sviggum, Mark D P Davis, S Vincent Rajkumar, et al.
Neurology|September 12, 2007
Primary systemic amyloidosis with ischemic stroke as a presenting complicationAlexander Y Zubkov, Alejandro A Rabinstein, Angela Dispenzieri, et al.
JACC. Cardiooncology|June 19, 2025
Reply: Cardiac Biomarkers in Patients With Suspected Amyloid (Transthyretin) Cardiomyopathy: Which Cut-Offs?Laura De Michieli, Omar F AbouEzzeddine, Angela Dispenzieri, et al.
Journal of the American College of Cardiology|September 24, 2021
Cardiac Amyloidosis in Patients With Persistent Left Atrial ThrombusEdward A El-Am, Ali Ahmad, Angela Dispenzieri, et al.
International Journal of Molecular Sciences|November 20, 2013
Thermal stability threshold for amyloid formation in light chain amyloidosisTanya L Poshusta, Nagaaki Katoh, Morie A Gertz, et al.
International Journal of Cancer|February 2, 2021
Chemotherapy-based approach is the preferred treatment for sporadic late-onset nemaline myopathy with a monoclonal proteinRouslan Kotchetkov, David Susman, Divaya Bhutani, et al.
International Journal of Cancer|March 20, 2021
Reply to: Comments on: Chemotherapy-based approach is the preferred treatment for sporadic late-onset nemaline myopathy with a monoclonal proteinRouslan Kotchetkov, David Susman, Divaya Bhutani, et al.
Current Opinion in Oncology|February 3, 2007
Transplantation for amyloidosisMorie A Gertz, Martha Q Lacy, Angela Dispenzieri, et al.
Pageof 91